Vascular response to everolimus- and biolimus-eluting coronary stents versus everolimus-eluting bioresorbable scaffolds – an optical coherence tomography substudy of the EVERBIO II trial. Swiss Medical Weekly, [S. l.], v. 146, n. 0102, p. w14274, 2016. DOI: 10.4414/smw.2016.14274. Disponível em: https://smw.ch/index.php/smw/article/view/2139. Acesso em: 29 oct. 2025.